Citation Impact
Citing Papers
Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1
2010
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Arterial-Venous Segregation by Selective Cell Sprouting: An Alternative Mode of Blood Vessel Formation
2009 Science
Characteristics and Roles of Exosomes in Cardiovascular Disease
2017
Hallmarks of Cancer: The Next Generation
2011 Standout
Nitric Oxide Is an Upstream Signal of Vascular Endothelial Growth Factor-induced Extracellular Signal-regulated Kinase½ Activation in Postcapillary Endothelium
1998
Cutaneous Wound Healing
1999 Standout
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
1999 StandoutNature
Endogenous inhibitors of angiogenesis
2009
Kringle Domains of Human Angiostatin
1996
Significance of tumor-host interactions in cancer growth and metastases
1995
ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins
2007 Standout
Solution Structure of Human Prolactin
2005
Deep Sequencing of RNA from Three Different Extracellular Vesicle (EV) Subtypes Released from the Human LIM1863 Colon Cancer Cell Line Uncovers Distinct Mirna-Enrichment Signatures
2014
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
Ovarian cancer biomarkers for molecular biosensors and translational medicine
2010
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis
2015
Endometriosis
2009 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
2017
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
2019 StandoutNobel
Immunobiology of endometriosis
2001
Should prolactin be reconsidered as a therapeutic target in human breast cancer?
1999
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody
1999
Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity
2016
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Diabetic Retinopathy
2012 Standout
Angiogenic Factors in Endometriosis
2002
Vascular permeability factor/vascular endothelial growth factor:A multifunctional angiogenic cytokine
1997
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
De novo expression of vascular endothelial growth factor in human pancreatic cancer: Evidence for an autocrine mitogenic loop
2000
Emerging Biological Principles of Metastasis
2017 Standout
Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye
2014
Targeting metastasis
2016
The Origin and Functions of Exosomes in Cancer
2018
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Cathepsin D—Many functions of one aspartic protease
2008
Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles
2018
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Endometriosis
2004 Standout
Mechanisms of angiogenesis and arteriogenesis
2000 Standout
Redox signaling in vascular angiogenesis1,2 1Guest Editor: Toshikazu Yoshikawa 2This article is part of a series of reviews on “Vascular Dysfunction and Free Radicals.” The full list of papers may be found on the homepage of the journal.
2002
Norrin, Frizzled-4, and Lrp5 Signaling in Endothelial Cells Controls a Genetic Program for Retinal Vascularization
2009
Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases
2017
Prolactin: A Hormone at the Crossroads of Neuroimmunoendocrinology
1998
Reassessment of Exosome Composition
2019 Standout
Role of vascular endothelial growth factor in the regulation of angiogenesis
1999
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Vascular Endothelial Growth Factor Signals Endothelial Cell Production of Nitric Oxide and Prostacyclin through Flk-1/KDR Activation of c-Src
1999
Angiogenesis and angiogenesis inhibition: An overview
1997
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer
2017
Antagonistic Properties of Human Prolactin Analogs That Show Paradoxical Agonistic Activity in the Nb2 Bioassay
1996
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Extracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large Oncosomes
2015
Inhibition of malignant angiogenesis
1997
Endogenous Inhibitors of Angiogenesis
2005
Caenorhabditis elegans ALG-1 antimorphic mutations uncover functions for Argonaute in microRNA guide strand selection and passenger strand disposal
2015 StandoutNobel
Suppression of the Raf/MEK/ERK Signaling Cascade and Inhibition of Angiogenesis by the Carboxyl Terminus of Angiopoietin-Like Protein 4
2008
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
2000 StandoutNobel
Arterial–Venous Specification During Development
2009
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Isolation and Characterization of Noncytopathic Pestivirus Mutants Reveals a Role for Nonstructural Protein NS4B in Viral Cytopathogenicity
2001 StandoutNobel
The heparin binding 25 kDa fragment of thrombospondin‐1 promotes angiogenesis and modulates gelatinase and TIMP‐2 production in endothelial cells
2000
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Vascular Endothelial Growth Factor Activates Nuclear Factor of Activated T Cells in Human Endothelial Cells: a Role for Tissue Factor Gene Expression
1999
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Dual Mechanisms of Pestiviral Superinfection Exclusion at Entry and RNA Replication
2005 StandoutNobel
The NS5A Protein of Bovine Viral Diarrhea Virus Contains an Essential Zinc-Binding Site Similar to That of the Hepatitis C Virus NS5A Protein
2006 StandoutNobel
Going live with tumor exosomes and microvesicles
2017
Function of IRE1 alpha in the placenta is essential for placental development and embryonic viability
2009 StandoutNobel
Modulation of three key innate immune pathways for the most common retinal degenerative diseases
2018
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
High Levels of Serum Prolactin Protect Against Diabetic Retinopathy by Increasing Ocular Vasoinhibins
2010
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Requirement of the MADS-box transcription factor MEF2C for vascular development
1998
Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1
1999 StandoutNobel
Vascular Endothelial Cell Growth Factor–Induced Tissue Factor Expression in Endothelial Cells Is Mediated by EGR-1
1999
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Development of Recombinant Human Prolactin Receptor Antagonists by Molecular Mimicry of the Phosphorylated Hormone*
1998
Regulation of angiogenesis via vascular endothelial growth factor receptors.
2000
Exosomal miRNAs as cancer biomarkers and therapeutic targets
2016
Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice
2009
Angiogenesis in Endocrine Tumors
2003
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
1998 Standout
Peritoneal fluid environment in endometriosis. Clinicopathological implications.
2003
Serine protease of pestiviruses: determination of cleavage sites
1997
Proliferin Induces Endothelial Cell Chemotaxis through a G Protein-Coupled, Mitogen-Activated Protein Kinase-Dependent Pathway*
1997
Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis
1998
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Efficient Translation Initiation Is Required for Replication of Bovine Viral Diarrhea Virus Subgenomic Replicons
2001 StandoutNobel
Infectious Bovine Viral Diarrhea Virus (Strain NADL) RNA from Stable cDNA Clones: a Cellular Insert Determines NS3 Production and Viral Cytopathogenicity
1998 StandoutNobel
Works of Ingrid Struman being referenced
Inhibition of Tumor Growth and Metastasis Establishment by Adenovirus-mediated Gene Transfer Delivery of the Antiangiogenic Factor 16K hPRL
2007
The addition of nine residues at the C‐terminus of human prolactin drastically alters its biological properties
1993
Zebrafish Sox7 and Sox18 function together to control arterial–venous identity
2008
Stabilization of T7-promoter-based pARHS expression vectors using the parB locus
1992
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
2013
Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice
2013
miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization
2014
NF-κB activation in endothelial cells is critical for the activity of angiostatic agents
2009
Evidence for a second receptor binding site on human prolactin.
1994
Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-/-) mice.
2001
The Antiangiogenic Factor, 16-kDa Human Prolactin, Induces Endothelial Cell Cycle Arrest by Acting at Both the G0–G1 and the G2–M Phases
2005
Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin.
1995
Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes
2016
Molecular Targeting of Antiangiogenic Factor 16K hPRL Inhibits Oxygen-Induced Retinopathy in Mice
2004
Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis
1999
Cathepsin D Processes Human Prolactin into Multiple 16K-Like N-Terminal Fragments: Study of Their Antiangiogenic Properties and Physiological Relevance
2004
Inhibition of Urokinase Activity by the Antiangiogenic Factor 16K Prolactin: Activation of Plasminogen Activator Inhibitor 1 Expression
1998
Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer
2015
Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR‐34a and miR‐122 Expression
2014